articleJournal of Clinical InvestigationDec 14, 2014BRONZE OA

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Peking University · Pennsylvania State University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a major worldwide health problem. Recent studies suggest that the gut microbiota influences NAFLD pathogenesis. Here, a murine model of high-fat diet-induced (HFD-induced) NAFLD was used, and the effects of alterations in the gut microbiota on NAFLD were determined. Mice treated with antibiotics or tempol exhibited altered bile acid composition, with a notable increase in conjugated bile acid metabolites that inhibited intestinal farnesoid X receptor (FXR) signaling. Compared with control mice, animals with intestine-specific Fxr disruption had reduced hepatic triglyceride accumulation in response to a HFD. The decrease in hepatic triglyceride accumulation was mainly…

Citation impact

669
total citations
FWCI
19.99
Percentile
100%
References
69
Citations per year

Authors

16

Topics & keywords

Keywords
  • Farnesoid X receptor
  • Nonalcoholic fatty liver disease
  • Ceramide
  • Internal medicine
  • Endocrinology
  • Lipogenesis
  • Gut flora
  • Steatosis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.